RJFSA
RLAY icon

Raymond James Financial Services Advisors’s Relay Therapeutics RLAY Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$709K Buy
100,073
+35,808
+56% +$268K ﹤0.01% 2393
2024
Q2 		$419K Buy
64,265
+9,377
+17% +$64.1K ﹤0.01% 2661
2024
Q1 		$456K Sell
54,888
-3,465
-6% -$33.8K ﹤0.01% 2589
2023
Q4 		$642K Sell
58,353
-1,681
-3% -$14.2K ﹤0.01% 2252
2023
Q3 		$505K Buy
60,034
+1,300
+2% +$14K ﹤0.01% 2325
2023
Q2 		$738K Buy
+58,734
New +$731K ﹤0.01% 2103

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Raymond James Financial Services Advisors's RLAY Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Relay Therapeutics (RLAY) stake by 56% in Q3 2024, buying an estimated $268K and bringing the position to 100,073 shares worth $709K. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

Raymond James Financial Services Advisors first reported a position in RLAY in Q2 2023 and has held it in 6 quarters since. The position peaked at $738K in Q2 2023. 195 funds tracked by Wall St. Rank hold RLAY as of Q3 2024.

  • Raymond James Financial Services Advisors held 100,073 shares of Relay Therapeutics worth $709K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 35,808 Relay Therapeutics shares in Q3 2024, an estimated $268K.
  • Relay Therapeutics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2393 holding.
  • Raymond James Financial Services Advisors first reported a position in Relay Therapeutics in Q2 2023 and has held it in 6 quarters since.
  • Raymond James Financial Services Advisors's Relay Therapeutics position peaked at $738K in Q2 2023.
  • 195 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.